, the incidence of restenosis/blockade is significantly higher than clinical restenosis because many patients have mild restenosis that does not result in a recurrence of symptoms.
The management of clinical restenosis/blockade is usually to repeat the PCI with balloon dilatation
and placement of a drug-eluting stent
Once a patient has had restenosis, the risk of the second restenosis is further increased.
The risk factors for restenosis are diabetes
, myocardial infarction
, long lesions, small diameter vessels, and suboptimal initial PCI result.
Anti-platelet drugs (aspirin,clopidrogel) and statin +/- nitrates are all that are required for those patients who are unwilling for Target lesion revascularization (TLR) or target vessel revascularization (TVR).
Hope I have answered your query. Let me know if I can assist you further.
Dr Tushar Kanti Biswas, Internal Medicine Specialist